A raft of top firms including Freshfields Bruckhaus, Deringer, Kirkland & Ellis, DLA Piper and Ashurst are advising on the £4.5 billion buy-out of veterinary pharmaceutical group Dechra by a consortium headed up by Scandinavian private equity giants EQT.